Literature DB >> 35275391

A case of ischemic stroke secondary to varicella-zoster virus meningoencephalitis.

Hangfei Wu1, Jiasi Li1, Ruoru Wang1, Chao Chen1, Xiaojun Hou2, Xiaoying Bi3.   

Abstract

Varicella-zoster virus (VZV) lurks in cranial nerves and other brain ganglias after infection. Because middle cerebral artery (MCA) receives the ipsilateral trigeminal ganglia afferent innervations, the reactivated VZV infects the adventitia and intima of cerebral artery wall probably through this way and causes vascular inflammation, finally resulting in artery remodeling, vessel occlusion, and ischemia. In fact, there is a growing clinical recognition that there is an association between VZV reactivation and subsequent stroke. Here, we showed a case of ischemic stroke secondary to varicella-zoster virus meningoencephalitis and reviewed the literature to emphasize the importance of VZV-associated vasculopathy.
© 2022. Journal of NeuroVirology, Inc.

Entities:  

Keywords:  High resolution magnetic resonance imaging; Ischemic stroke; Varicella-zoster virus; Vascular inflammation

Mesh:

Year:  2022        PMID: 35275391     DOI: 10.1007/s13365-022-01050-x

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  10 in total

1.  Varicella zoster virus vasculopathy: analysis of virus-infected arteries.

Authors:  M A Nagel; I Traktinskiy; Y Azarkh; B Kleinschmidt-DeMasters; T Hedley-Whyte; A Russman; E M VanEgmond; K Stenmark; M Frid; R Mahalingam; M Wellish; A Choe; R Cordery-Cotter; R J Cohrs; D Gilden
Journal:  Neurology       Date:  2011-07-13       Impact factor: 9.910

Review 2.  Neurological complications of varicella zoster virus reactivation.

Authors:  Maria A Nagel; Don Gilden
Journal:  Curr Opin Neurol       Date:  2014-06       Impact factor: 5.710

Review 3.  Clinical management of infectious cerebral vasculitides.

Authors:  Francisco Javier Carod Artal
Journal:  Expert Rev Neurother       Date:  2016-01-19       Impact factor: 4.618

4.  High-resolution MRI vessel wall imaging in varicella zoster virus vasculopathy.

Authors:  Esteban Cheng-Ching; Stephen Jones; Ferdinand K Hui; Shumei Man; Don Gilden; Adarsh Bhimraj; Ken Uchino
Journal:  J Neurol Sci       Date:  2015-02-16       Impact factor: 3.181

5.  Multicontrast high-resolution vessel wall magnetic resonance imaging and its value in differentiating intracranial vasculopathic processes.

Authors:  Mahmud Mossa-Basha; William D Hwang; Adam De Havenon; Daniel Hippe; Niranjan Balu; Kyra J Becker; David T Tirschwell; Thomas Hatsukami; Yoshimi Anzai; Chun Yuan
Journal:  Stroke       Date:  2015-05-07       Impact factor: 7.914

Review 6.  Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment.

Authors:  Don Gilden; Randall J Cohrs; Ravi Mahalingam; Maria A Nagel
Journal:  Lancet Neurol       Date:  2009-08       Impact factor: 44.182

Review 7.  The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features.

Authors:  M A Nagel; R J Cohrs; R Mahalingam; M C Wellish; B Forghani; A Schiller; J E Safdieh; E Kamenkovich; L W Ostrow; M Levy; B Greenberg; A N Russman; I Katzan; C J Gardner; M Häusler; R Nau; T Saraya; H Wada; H Goto; M de Martino; M Ueno; W D Brown; C Terborg; D H Gilden
Journal:  Neurology       Date:  2008-03-11       Impact factor: 9.910

8.  Childhood primary angiitis of the central nervous system.

Authors:  Muhammad Akbar Malik; Muhammad Zia-ur-Rehman; Malik Muhammad Nadeem; Farooq Rasool Chaudhry; Abid Ali Qureshi; Muhammad Nawaz; Hamza Malik
Journal:  J Coll Physicians Surg Pak       Date:  2012-09       Impact factor: 0.711

9.  Etiological profile of stroke and its relation with prothrombotic states.

Authors:  Sonia Makhija; Satinder Aneja; R P Tripathi; Shashi Narayan
Journal:  Indian J Pediatr       Date:  2008-08-31       Impact factor: 1.967

10.  Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry.

Authors:  M R Mayberg; N T Zervas; M A Moskowitz
Journal:  J Comp Neurol       Date:  1984-02-10       Impact factor: 3.215

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.